New principles for the treatment of diabetes are described in this volume. Experts present experimental and clinical data on treatment with acarbose, an alpha-glucosidase inhibitor that delays absorption of fast carbohydrates. Toxicologic, pharmacologic and metabolic effects of acarbose are discussed. A concluding section on the future aspects of alpha-glucosidase inhibition offers a fair assessment of therapeutic possibilities.
